Comparison and validation of genomic predictors for anticancer drug sensitivity.

CONCLUSION: These results suggest that genomic predictors could be robustly validated for specific drugs. If successfully validated in patients' tumor cells, and subsequently in clinical trials, they could act as companion tests for the corresponding drugs and play an important role in personalized medicine.
PMID: 23355484 [PubMed - as supplied by publisher]

Source: Journal of the American Medical Informatics Association - January 26, 2013 Category: Information Technology Authors: Papillon-Cavanagh S, De Jay N, Hachem N, Olsen C, Bontempi G, Aerts HJ, Quackenbush J, Haibe-Kains B Tags: J Am Med Inform Assoc Source Type: research